V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20037905 | 20086052 | 1.66 | 90.9 | 03 | 2019-10-13 | 2019-10-23 | CHOP R - 21 days | 02 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101027309 |
| 20037992 | 20086053 | 0 | 52 | 03 | 2016-10-30 | 2016-10-30 | ARISTOTLE TRIAL | 02 | N | HYDROXYCARBAMIDE | 101319705 |
| 20038150 | 20086054 | 1.75 | 71 | 03 | 2019-03-19 | 2019-03-28 | null | N | N | ECARBOX | 101402755 |
| 20038160 | 20086055 | 1.74 | 89 | Curative (C) | 2017-01-19 | 2017-02-17 | MPV (cycle 1-4) | 02 | N | ARISTOTLE TRIAL | 101205201 |
| 20038179 | 20086056 | null | 76 | null | 2017-09-03 | 2017-09-05 | PEMBROLIZUMAB | 02 | N | PERTUZUMAB | 101787698 |
| 20038198 | 20086057 | null | null | Palliative (P) | 2019-06-26 | 2019-07-16 | ESPAC-4 TRIAL | 02 | N | RITUXIMAB | 101397803 |
| 20038222 | 20086059 | 1.5 | null | Palliative (P) | 2017-11-07 | 2017-11-07 | BRIGATINIB | 02 | N | RITUXIMAB | 100687412 |
| 20038232 | 20086060 | 1.73 | 88 | 03 | 2018-11-13 | 2018-11-19 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101522880 |
| 20038256 | 20086061 | 1.8 | 80.4 | 03 | 2017-12-25 | 2018-01-05 | OXALIPLATIN + MDG + PANITUMUMAB | N | N | BCG | 101711706 |
| 20038280 | 20086062 | 1.73 | 57.4 | null | 2017-01-01 | 2017-01-25 | EVEROLIMUS | null | N | FOXTROT TRIAL | 101510817 |
| 20038301 | 20086063 | 1.46 | 63.3 | 03 | 2018-03-07 | 2018-03-13 | Raltitrexed | 99 | Y | CYCLOPHOSPHAMIDE | 100897782 |
| 20038348 | 20086065 | 1.7 | 62.7 | 03 | 2017-10-06 | 2017-10-07 | Venetoclax | null | N | CARBOPLATIN + PEMETREXED | 101650448 |
| 20038355 | 20086066 | 1.79 | 112 | Neo-adjuvant (N) | null | 2018-01-09 | Hydroxycarbamide | 01 | N | DOXORUBICIN + OLARATUMAB | 100395340 |
| 20038381 | 20086067 | 1.52 | 74.4 | null | 2019-11-13 | 2019-11-18 | Pemetrexed | 01 | N | ANAGRELIDE | 101686671 |
| 20038441 | 20086068 | 1.53 | 104.05 | Palliative (P) | 2016-05-10 | 2016-05-22 | null | 01 | N | CISPLATIN + FLUOROURACIL + RT | 100743211 |
| 20038463 | 20086069 | 1.71 | 75 | 03 | 2017-03-03 | 2017-03-08 | Palbociclib | 02 | N | IBRUTINIB | 100551030 |
| 20038481 | 20086070 | 1.75 | 86.3 | Adjuvant (A) | 2017-08-15 | 2017-09-23 | Capecitabine+Cisplatin+Streptozocin | 02 | N | DOCETAXEL | 100229133 |
| 20038517 | 20086071 | 1.81 | 59 | Palliative (P) | 2019-03-09 | 2019-03-23 | GO2 TRIAL | 02 | N | MYELOMA XIV TRIAL | 101083857 |
| 20038530 | 20086072 | 1.7 | 101 | Palliative (P) | 2017-02-19 | 2017-03-05 | PACLITAXEL | N | N | CISPLATIN + FU + TRASTUZUMAB | 101472991 |
| 20038535 | 20086073 | 1.73 | 68.2 | Palliative (P) | null | 2016-10-14 | EVEROLIMUS | 01 | null | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 100972356 |
| 20038585 | 20086075 | 1.69 | 59.7 | 03 | 2020-08-08 | 2020-08-20 | ECarboX | 02 | Y | CISPLATIN + FLUOROURACIL + RT | 101363795 |
| 20038639 | 20086076 | 1.58 | null | 03 | 2020-02-11 | 2020-02-11 | CYCLOPHOSPHAMIDE | N | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100054199 |
| 20038640 | 20086077 | 1.57 | 60.8 | 03 | 2018-03-05 | 2018-03-13 | null | 99 | N | RITUXIMAB | 100735209 |
| 20038701 | 20086079 | 1.77 | 88.3 | Adjuvant (A) | 2019-09-25 | 2019-10-19 | Gemcitabine + Oxaliplatin | N | N | GEMCARBO | 101555665 |
| 20038705 | 20086080 | 1.58 | 80 | Palliative (P) | null | 2018-06-12 | Docetaxel 100mg/m2 (21 day) | 01 | null | PHITT | 100777407 |
| 20038720 | 20086081 | 1.63 | 49 | null | 2019-10-28 | 2019-11-07 | EOF | 02 | null | PEMBROLIZUMAB | 101682257 |
| 20038727 | 20086082 | 1.75 | 54 | Palliative (P) | 2019-05-01 | 2019-05-25 | CHOP R - 21 days | 02 | N | CARBOPLATIN + FLUOROURACIL | 101264185 |
| 20038741 | 20086083 | 1.63 | 53.5 | null | null | 2017-10-07 | ACELARATE Trial | N | N | FEC + DOCETAXEL | 100788364 |
| 20038796 | 20086084 | 1.7 | 84.8 | Adjuvant (A) | 2019-06-05 | 2019-06-30 | MIC | 01 | N | MELPHALAN + THALIDOMIDE | 101806289 |
| 20038959 | 20086089 | 1.68 | 75.9 | null | 2019-05-03 | 2019-05-24 | AML18 PILOT TRIAL | N | N | ECARBOX | 100795839 |
| 20038975 | 20086090 | 1.63 | 60.9 | Palliative (P) | 2020-07-18 | 2020-08-14 | GEMCARBO | null | N | CAPECITABINE + CARBOPLATIN + RT | 100256842 |
| 20039038 | 20086091 | 1.76 | 98.8 | Palliative (P) | 2009-09-01 | 2018-07-05 | CARBOPLATIN + FLUOROURACIL | 02 | N | PEMBROLIZUMAB | 100951668 |
| 20039039 | 20086092 | 1.73 | 89 | 03 | 2017-03-29 | 2017-03-29 | CHOP R | 02 | N | CAP + RT | 101152164 |
| 20039046 | 20086093 | 1.74 | 72.7 | Adjuvant (A) | 2018-09-27 | 2018-09-27 | Docetaxel | 02 | N | DOCETAXEL | 101295422 |
| 20039106 | 20086096 | 1.55 | 85.9 | 03 | 2018-11-07 | 2018-11-14 | EOF | N | N | DOCETAXEL | 101612588 |
| 20039133 | 20086097 | null | 55.9 | 03 | 2019-05-21 | 2019-05-24 | Docetaxel 75mg/m2 (21 day) | null | N | CARBOPLATIN + PEMETREXED | 100037948 |
| 20039175 | 20086098 | 1.51 | 79.9 | Palliative (P) | 2021-06-12 | 2021-06-17 | Topotecan (oral) | 01 | N | ABIRATERONE | 100058274 |
| 20039200 | 20086099 | 1.62 | 63.5 | Adjuvant (A) | 2020-01-29 | 2020-02-12 | ARISTOTLE TRIAL | 02 | N | ABIRATERONE | 100859091 |
| 20039229 | 20086101 | 1.57 | 41 | 03 | 2014-02-25 | 2014-02-25 | PACLITAXEL | 02 | N | DOXORUBICIN + OLARATUMAB | 100070514 |
| 20039320 | 20086102 | 1.69 | 74 | Adjuvant (A) | 2019-12-10 | 2019-12-18 | PLATO Trials | null | N | PLATO TRIAL | 101592294 |
| 20039339 | 20086103 | 1.6 | 92 | 03 | 2017-09-03 | 2017-09-03 | Paclitaxel 80mg/m2 day 1 8 15 | 01 | Y | CISPLATIN + FLUOROURACIL + RT | 100562505 |
| 20039423 | 20086104 | 1.66 | 51 | Adjuvant (A) | 2017-06-29 | 2017-07-04 | HEP HR Hepatoblastoma guide cisp | null | N | CARBO + FLUOROURACIL | 100458458 |
| 20039454 | 20086105 | 1.68 | 50.4 | Palliative (P) | 2018-01-04 | 2018-01-09 | CARBOPLATIN + RT | 02 | N | CAPECITABINE + CARBOPLATIN + RT | 100045295 |
| 20039470 | 20086106 | 1.85 | 62 | 03 | 2017-06-27 | 2017-06-30 | Raltitrexed | 02 | N | PACLITAXEL | 101519208 |
| 20039510 | 20086107 | 1.54 | 79.7 | Adjuvant (A) | 2020-01-07 | 2020-01-07 | PEMBROLIZUMAB | 01 | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101700172 |
| 20039511 | 20086108 | 1.54 | null | 03 | 2017-05-25 | 2017-05-25 | CISPLATIN + FLUOROURACIL + RT | 01 | N | ABIRATERONE | 101614172 |
| 20039559 | 20086110 | 0 | 0 | Palliative (P) | 2019-04-03 | 2019-04-03 | ACTICCA-1 Trial | 02 | N | LENALIDOMIDE | 101090991 |
| 20039560 | 20086111 | 1.7 | 50.7 | Palliative (P) | 2017-03-28 | 2017-04-07 | Nilotinib | 02 | N | CAPECITABINE + CARBOPLATIN + RT | 100586101 |
| 20039561 | 20086112 | 1.6 | null | 03 | 2019-08-15 | 2019-08-15 | Docetaxel 75mg/m2 (21 day) | 02 | N | NEO-AEGIS TRIAL | 101410267 |
| 20039565 | 20086113 | 1.58 | 91.1 | Palliative (P) | 2017-05-15 | 2017-05-29 | SCOPE 2 TRIAL | 01 | N | OXALIPLATIN + MDG + PANITUMUMAB | 101266966 |